Peter Heerma
Net worth: 7 M $ as of 2026-05-30
Net worth: 7 M $ as of 2026-05-30
Peter Heerma currently works at Travere Therapeutics, Inc., as Chief Commercial Officer from 2019.
Mr. Heerma also formerly worked at Abbott Laboratories, as Director-Commercial Strategy Renal Care from 2003 to 2012, AbbVie, Inc., as Senior Director-Portfolio Strategy from 2012 to 2015, and Amgen, Inc., as GM-Oncology & Cardiovascular Products from 2015 to 2019.
Mr. Heerma received his graduate degree in 1997 from the University of Lund and undergraduate degree in 1996 from Stenden University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-04 | 140,684 ( 0.15% ) | 7 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Corporate Officer/Principal | 2019-09-30 |
| Companies | Position | End |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 2019-08-31 |
| ABBVIE INC. | Corporate Officer/Principal | 2015-10-31 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 2012-10-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stenden University
Stenden University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Travere Therapeutics, Inc.
Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions